more_reports
BLGO:OTCQX

BioLargo Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Its core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Its business approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

BioLargo Inc. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.

Recent Articles:

Clean Tech Co. Takes 'Forever Chemicals' Solution to NY Conference

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX), which has developed technology to "forever chemicals" from water, will participate in a symposium on the contaminants in New York. One analyst says the company's growing validation in the field should "not be overlooked."

Cleantech Co. is Grossly Undervalued, Says Analyst

Research Report
  ()
The Buy-rated company continues growing revenue and developing multiple lines of business, noted a Singular Research report.

Cleantech Co. Increases Revenue, Cash Flow in Q2/24

Research Report
  ()
The company's Pooph line of pet odor eliminating products "continues to experience strong commercialization growth," noted an Oak Ridge Financial Research report.

Pet Odor Product Continues to Be Lucrative for Clean Tech Co.

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) continues to see rising revenues with strong year-over-year and quarter-over-quarter growth. Find out why one analyst recommends investors look at the stock.

Clean Tech Co. Continues to See Rising Revenues

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announces preliminary financial results for the second quarter ending June 30, 2024, including a 247% increase in revenue QoQ. One analyst says the stock is headed for an upleg.

'Everyone's Drinking It': More 'Forever Chemicals' Showing Up Worldwide

  ()
So-called "forever chemicals" used by industry in water and food are becoming more ubiquitous worldwide, researchers said, even in lithium-ion batteries powering the energy transition. One company has solutions.

More Articles


Expert Comments:

Gowshihan Sriharan, Singular Research

(8/30/24)
"BioLargo Inc. delivered 247% year-over-year revenue growth in Q2/24, ahead of our estimates. Pooph revenue continues to grow rapidly, and the company's first PFAS remediation project is on track for completion by Q4/24. We are bullish on BioLargo's long-term prospects."

Richard Ryan, Oak Ridge Financial

(8/16/24)
"BioLargo Inc. announced Q2/24 revenues that again showed strong year-over-year and modest quarter-over-quarter growth. Revenues were $5M, up from $1.4M a year ago and up 5% sequentially as Pooph sales saw continued good performance."

Richard Ryan, Oak Ridge Financial

(5/16/24)
"BioLargo Inc. announced Q1/24 revenues that again showed strong year-over-year and quarter-over-quarter growth. The company generated positive cash flow from operations and increased its shareholders' equity to $5.1M, all while maintaining minimal debt and ending the quarter with $4.3M in cash."

Richard Ryan, Oak Ridge Financial

(4/17/24)
"The final PFAS regulations from the Environmental Protection Agency validate BioLargo Inc.'s water treatment vision. . .under the new rule, water utilities must monitor PFAS chemicals and would be required to notify the public and reduce contamination if levels exceeded the new standard. . .the large emerging market for PFAS removal and the company's growing validation in this opportunity should not be overlooked."

Richard Ryan, Oak Ridge Financial

(4/4/24)
"BioLargo Inc. announced that 2023 revenues more than doubled the level the company reported in 2022, making it the second year in a row that revenues have grown at that rate. BioLargo maintained gross margin at 50%, doubled shareholders' equity, all while maintaining minimal debt and ending the year with $3.5M in cash."

Clive Maund, CliveMaund.com

(2/14/24)
"The fundamentals of BioLargo Inc. are superb with everything coming together in a positive manner after many years of work. So ultimately, the company's stock is believed headed much higher."

More Expert Comments

Experts Following This Company

Clive Maund – CliveMaund.com
Richard Ryan – Oak Ridge Financial
Gowshihan Sriharan – Singular Research
headshot of Chris Temple
Chris Temple, Editor and Publisher – The National Investor

Company News 

8/13/2024 – BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time

8/6/2024 – BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024

Important Disclosures
BioLargo Inc. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases. The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content. Billboard advertising monthly fees range from $3,000 to $5,000. This landing page contains a summary of the company that was prepared by that company. Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company. The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports. There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page. Readers should conduct their own research for all information publicly available concerning the company. This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.

streetwise book logoStreetwise - BioLargo Inc. Ownership Overview*

BioLargo Inc. (BLGO:OTCQB)

*Share Structure as of 2/20/2024
Investing Highlights
 
Invest-prove-partner business model that leverages credible partners to maximize impact
 
Unrivaled technologies to solve challenges in emerging environmental markets
 
Heading toward profitability, with average QoQ revenue growth of +25% over past two years